Individualized Homeopathic Medicines in the Management of Symptomatic Adenotonsillar Hypertrophy in Children: A Prospective Observational Study.

Autor:	Ponnam HB; Department of Clinical Research, Regional Research Institute for Homoeopathy, Hyderabad, Telangana, India., Varanasi R; Department of Clinical Research, Central Council for Research In Homoeopathy, New Delhi, India., Shil RC; Department of Clinical Research, Regional Research Institute for Homoeopathy, Agartala, India., R VE; Department of Clinical Research, National Homoeopathy Research Institute for Mental Health, Kottayam, Kerala, India., Goel M; Department of Clinical Research, Dr. D P Rastogi Central Research Institute for Homoeopathy, New Delhi, India., Ramteke S; Department of Clinical Research, Dr. D P Rastogi Central Research Institute for Homoeopathy, New Delhi, India., Karthikeyan D; Department of Clinical Research, Homoeopathy Research Institute for Disabilities, Chennai, Tamil Nadu, India., Arya DD; Department of Clinical Research, Dr. D P Rastogi Central Research Institute for Homoeopathy, New Delhi, India., Swain TL; Department of Clinical Research, Regional Research Institute for Homoeopathy, Agartala, India., Bagdi N; Department of Clinical Research, Central Council for Research In Homoeopathy, New Delhi, India., Srivastava P; Department of Clinical Research, Central Council for Research In Homoeopathy, New Delhi, India., Manchanda RK; Department of Clinical Research, Directorate of AYUSH, NCT Delhi, India., Oberai P; Department of Clinical Research, Central Council for Research In Homoeopathy, New Delhi, India.
Jazyk:	angličtina
Zdroj:	Homeopathy : the journal of the Faculty of Homeopathy [Homeopathy] 2024 Feb; Vol. 113 (1), pp. 32-40. Date of Electronic Publication: 2023 Apr 04.
DOI:	10.1055/s-0043-1762591
Abstrakt:	Background: Globally, adenotonsillar hypertrophy (ATH) is one of the most prevalent upper respiratory tract disorders of children, with associated troublesome symptoms such as sleep apnea and cognitive disturbances. In this study, we evaluated the potential role of individualized homeopathic medicines in the management of symptomatic ATH in children. Methods: A multicenter prospective observational study was conducted at five institutes under the Central Council for Research in Homoeopathy, India. Primary and secondary outcomes (symptom score for adenoids, other symptoms of ATH, Mallampati score, tonsillar size, Sleep-Related Breathing Disorder of the Paediatric Sleep Questionnaire [SRBD-PSQ]) were assessed through standardized questionnaires at baseline and at 3, 6, 9 and 12 months. Radiological investigations for assessing the adenoid/nasopharyngeal (A/N) ratio were carried out at baseline, 6 and 12 months. All analyses were carried out using an intention-to-treat approach. Results: A total of 340 children were screened and 202 children suffering from ATH were enrolled and followed up monthly for 12 months. Each patient received individualized homeopathic treatment based on the totality of symptoms. Statistically significant reductions in adenoid symptom score, Mallampati score (including tonsillar size), SRBD-PSQ sleep quality assessment and A/N ratio were found over time up to 12 months ( p  < 0.001). Homeopathic medicines frequently indicated were Calcarea carbonicum, Phosphorus, Silicea, Sulphur, Calcarea phosphoricum, Pulsatilla, Lycopodium and Tuberculinum . No serious adverse events were recorded during the study period. Conclusion: This study suggests that homeopathic medicines may play a beneficial role in the management of symptomatic ATH in children. Well-designed comparative trials are warranted. Competing Interests: None declared. (Faculty of Homeopathy. This article is published by Thieme.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu